Karolinska Development

Chiltern partners with Karolinska Development

Thursday, February 13, 2014

Global CRO Chiltern International has partnered with Karolinska Development, a Sweden-based life science investment company. Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations, along with other cooperation agreements with universities, delivers a continuous flow of innovations.

[Read More]